Literature DB >> 7829497

P450c11B3 mRNA, transcribed from a third P450c11 gene, is expressed in a tissue-specific, developmentally, and hormonally regulated fashion in the rodent adrenal and encodes a protein with both 11-hydroxylase and 18-hydroxylase activities.

S H Mellon1, S R Bair, H Monis.   

Abstract

The rat genome contains four P450c11 genes. One of these (CYP11B1) encodes P450c11 beta, which is the steroid 11 beta-hydroxylase found solely in the adrenal zona fasciculata/reticularis, and is responsible for the conversion of 11-deoxycorticosterone to corticosterone. A second P450c11 gene (CYP11B2) encodes P450c11AS, which is the aldosterone synthase found solely in the adrenal zona glomerulosa. P450c11AS has three activities, 11 beta-hydroxylase, 18-hydroxylase, and 18-oxidase, and is responsible for the conversion of 11-deoxycorticosterone to aldosterone. Recently, two more rat P450c11 genes, P450c11B3 and P450c11B4, were cloned. P450c11B4 appears to be a pseudogene, as two exons are replaced by unrelated DNA. P450c11B3 closely resembles P450c11 beta in mRNA and encoded amino acid sequences, predicting a protein of 498 amino acids. However, the expression of this mRNA and protein have not been demonstrated to date. We now demonstrate that this P450c11B3 mRNA is expressed in the adrenal gland several days after birth and is not expressed during fetal development or in the adult rat adrenal. Like P450c11 beta mRNA, P450c11B3 mRNA is expressed in the zona fasciculata/reticularis and not in the zona glomerulosa. However, the regulation of P450c11B3 mRNA expression is different from that of P450c11 beta mRNA, in that its abundance is decreased by ACTH in a sex-dependent fashion. Transfection of eukaryotic cells with a vector expressing P450c11B3 shows that this form of P450c11 can convert 11-deoxycorticosterone (DOC) to corticosterone and thus has the same enzymatic activity as P450c11 beta. In addition, P450c11B3 can convert DOC to 18-OH DOC and corticosterone to 18-OH corticosterone and thus has 18-hydroxylase activity similar to P450c11AS, but it lacks detectable 18-oxidase activity. Thus, P450c11B3 catalyzes 11 beta- and 18-hydroxylation and thus has a spectrum of activities midway between P450c11 beta and P450c11AS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7829497     DOI: 10.1074/jbc.270.4.1643

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  CYP11B2 expression in HSCs and its effect on hepatic fibrogenesis.

Authors:  Xu Li; Ying Meng; Xi-Shan Yang; Ping-Sheng Wu; Shu-Mei Li; Wen-Yan Lai
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 2.  Hedgehog signaling and steroidogenesis.

Authors:  Isabella Finco; Christopher R LaPensee; Kenneth T Krill; Gary D Hammer
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

Review 3.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

Review 4.  Human cytochromes P450 in health and disease.

Authors:  Daniel W Nebert; Kjell Wikvall; Walter L Miller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-06       Impact factor: 6.237

5.  Mutation T318M in the CYP11B2 gene encoding P450c11AS (aldosterone synthase) causes corticosterone methyl oxidase II deficiency.

Authors:  G Zhang; H Rodriguez; C E Fardella; D A Harris; W L Miller
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

6.  Identification of functional consequence of a novel selection signature in CYP11b1 gene for milk fat content in Bubalus bubalis.

Authors:  J Maryam; Masroor Ellahi Babar; Asif Nadeem; Tahir Yaqub; Abu Saeed Hashmi
Journal:  Meta Gene       Date:  2015-10-22

Review 7.  Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies.

Authors:  Andrew Midzak; Vassilios Papadopoulos
Journal:  Front Endocrinol (Lausanne)       Date:  2016-07-29       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.